BUB1 and plasma cell myeloma: Thus, further research is needed to clarify the mechanism underlying BUB1-mediated clonogenicity and tumorigenesis in myeloma cells, and this may also lead to the discovery of a novel therapeutic target, which could be functionally synthetic lethal.